News

Premier Research Names Kimberly Glen Executive Director for Rare Disease

DURHAM, N.C., JULY 24, 2017 — Premier Research has named Kimberly Glen an Executive Director for Rare Disease, Strategic Development Department. She brings to the company nearly three decades of experience in contract research, drug development, and pharmaceutical consulting. “Rare disease is an extremely demanding field of study, imposing unique challenges in patient recruitment, derivingRead more





Premier Research Joins TriNetX Global Health Research Network to Access Real-Time Site & Patient Metrics

DURHAM, N.C., JULY 21, 2017 — Premier Research, seeking to accelerate clinical trial design and patient recruitment to better serve its highly innovative customers, has signed an agreement with TriNetX to allow direct query access to its global health research network, comprised of healthcare organizations representing over 84 million patients globally. The Durham-based contract research organization will use TriNetX’s cloud-based platformRead more





Premier Research Names Susan Romberg Senior VP for Clinical Operations

DURHAM, N.C., JULY 18, 2017 — Premier Research has named Susan Romberg Senior Vice President for Clinical Operations. She brings deep industry and therapeutic experience to the role, which oversees global monitoring, clinical management, and document management. Ms. Romberg has worked in the contract research and pharma industries for more than 20 years, most recentlyRead more





Quality Assurance VP Speaking at Life Sciences Webcast July 20

DURHAM, N.C., June 29, 2017 — Premier Research’s head of quality assurance will speak on life sciences supplier certification during a webcast hosted by The Knowledge Group. The event takes place Thursday, July 20, from 3 p.m. to 5 p.m. Eastern. The Life Sciences’ Supplier and Contractor Qualification and Control Framework Explored will address challengesRead more





Coding Expert Joins B3/C3 Format Discussion at WHODrug Meeting

DURHAM, N.C., June 23, 2017 — A Premier Research medical coding expert will take part in a panel discussion on the new WHODrug B3 and C3 formats. Lubomir Tarabcak, Manager of Medical Coding, will be taking part in the hour-long panel at the WHODrug User Group Meeting, June 23 in Chicago. The discussion, to beginRead more





Quality Expert to Discuss Data Integrity at DIA Annual Meeting

DURHAM, N.C., June 19, 2017 — Data integrity has been a prime focus of pharmaceutical regulators for two decades now, but the focus is sharpening markedly with issuance of new guidance from multiple regulatory authorities. Sherri Hubby, who leads quality assurance, risk, and compliance at Premier Research, will address this trend and its implications atRead more





Risk-Based Decisions Topic of Panel Talk at Quality Consortium

DURHAM, N.C., June 7, 2017 — Premier Research’s leading quality expert will host a panel discussion on risk-based decision-making at the Avoca Quality Consortium’s 2017 summit in Dublin. The discussion, starting at 2:15 p.m. June 8, will address needs in transforming human capital management and improving risk mitigation in clinical trial execution. It’s an idealRead more





Webinar Explores Expanding Role of Immuno-Oncology Drugs

DURHAM, N.C., MAY 23, 2017 — Interleukin-2, interferon, and other immune-modulating agents have long been used to treat some solid malignancies, but their efficacy is generally limited to immunogenic cancers such as melanoma and kidney cancer. Until now. Today, multiple immuno-oncology pathways are under development, and we’ll explore this promising trend in a webinar onRead more





Premier Research Expert to Discuss Fibromyalgia at Pain Society Meeting

DURHAM, N.C., May 17, 2017 — Scott Millard, Premier Research’s head of analgesia strategic development, will speak on fibromyalgia clinical trials during a Town Hall Talk at the American Pain Society’s Annual Scientific Meeting, May 17-20 in Pittsburgh. Mr. Millard will present Operationalizing Clinical Trials in Fibromyalgia on Thursday, May 18, starting at 9:40 a.m.Read more





Premier Research Leads Panel on Patient-Centric Research at WODC Congress

DURHAM, N.C., April 20, 2017 — Premier Research’s Chief Medical Officer will lead a panel discussion on patient-centric research on April 20 at the World Orphan Drug Congress (WODC) in Washington, D.C. Dr. Colin Hayward will examine what patient-centricity means and where it’s taking the clinical research industry, joined by panelists Jayne Gershkowitz of AmicusRead more





Natural History or Registry Study? Conducting a Rare Disease Research

DURHAM, N.C., April 03, 2017 — You can’t beat a disease you don’t understand. Rare disease researchers, working with limited patient access and little historical data, know that reality all too well. Two methods prevail in collecting information for this research: registry studies and natural history studies. Premier Research will examine their characteristics and advantagesRead more





Therapeutic Revolution: A Webinar on the Fight Against Psoriasis

DURHAM, N.C., MARCH 27, 2017 — A therapeutic revolution is changing the lives of many afflicted with severe psoriasis. New treatments are breaking the cycle of patient “heartbreak” made famous in product advertising decades ago. Premier Research will explore these advances in a webinar on Wednesday, March 29. Dr. Howard Welgus, Executive Medical Director for Dermatology,Read more





Phone Us Now
Email Us Now